Saro H Armenian

Summary

Affiliation: City of Hope National Medical Center
Country: USA

Publications

  1. ncbi request reprint Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines
    Saro H Armenian
    Authors Affiliations Division of Outcomes Research, Department of Population Sciences, Department of Cardiology, City of Hope, Duarte Divisions of Hematology, Oncology, and Blood and Marrow Transplantation and Cardiology, Children s Hospital Los Angeles Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California and Division of Pediatric Cardiology, Department of Pediatrics and Communicable Diseases, C S Mott Children s Hospital, University of Michigan, Ann Arbor, Michigan
    Cancer Epidemiol Biomarkers Prev 23:1109-14. 2014
  2. pmc Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes
    Saro H Armenian
    Department of Population Sciences, City of Hope, Duarte, CA 91010 3000, USA
    Pediatr Blood Cancer 60:1063-8. 2013
  3. pmc Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease
    Saro H Armenian
    Department of Population Sciences, City of Hope, 1500 E Duarte Rd, Duarte, CA 91010 3000, USA
    Blood 120:4505-12. 2012
  4. pmc Childhood cancer survivorship: an update on evolving paradigms for understanding pathogenesis and screening for therapy-related late effects
    Saro H Armenian
    Department of Population Sciences, City of Hope National Medical Center, Duarte, California 91010 3000, USA
    Curr Opin Pediatr 25:16-22. 2013
  5. pmc Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation
    Saro H Armenian
    Department of Population Sciences, City of Hope, Duarte, CA 91010 3000, USA
    Blood 118:6023-9. 2011
  6. pmc Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study
    Can Lan Sun
    Department of Population Sciences, City of Hope National Medical Center, Duarte, CA, USA
    Biol Blood Marrow Transplant 19:1073-80. 2013
  7. pmc Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)
    Saro H Armenian
    Population Sciences, City of Hope, Duarte, CA 91010 3000, USA
    Blood 118:1413-20. 2011
  8. pmc Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation
    Saro H Armenian
    Department of Population Sciences, City of Hope, Duarte, California 91010 3000, USA
    Biol Blood Marrow Transplant 16:1138-44. 2010
  9. pmc Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
    Saro H Armenian
    Department of Population Sciences, City of Hope National Medical Center, Duarte, CA 91010 3000, USA
    Cancer 116:4152-9. 2010
  10. pmc Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines
    Wendy Landier
    City of Hope, Duarte, CA 91010 3000, USA
    J Clin Oncol 30:4401-8. 2012

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines
    Saro H Armenian
    Authors Affiliations Division of Outcomes Research, Department of Population Sciences, Department of Cardiology, City of Hope, Duarte Divisions of Hematology, Oncology, and Blood and Marrow Transplantation and Cardiology, Children s Hospital Los Angeles Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California and Division of Pediatric Cardiology, Department of Pediatrics and Communicable Diseases, C S Mott Children s Hospital, University of Michigan, Ann Arbor, Michigan
    Cancer Epidemiol Biomarkers Prev 23:1109-14. 2014
    ..Cancer Epidemiol Biomarkers Prev; 23(6); 1109-14. ©2014 AACR. ..
  2. pmc Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes
    Saro H Armenian
    Department of Population Sciences, City of Hope, Duarte, CA 91010 3000, USA
    Pediatr Blood Cancer 60:1063-8. 2013
    ..Ongoing health education initiatives have helped standardize the follow-up care for childhood cancer survivors and facilitate the early transfer of health-related information to patients, families, and healthcare providers...
  3. pmc Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease
    Saro H Armenian
    Department of Population Sciences, City of Hope, 1500 E Duarte Rd, Duarte, CA 91010 3000, USA
    Blood 120:4505-12. 2012
    ..7% [none], 7.0% [1 CVRF], 11.2% [≥ 2 CVRFs], P < .01); the risk was especially high (15.0%) in patients with multiple CVRFs and pre-HCT exposure to anthracyclines or chest radiation...
  4. pmc Childhood cancer survivorship: an update on evolving paradigms for understanding pathogenesis and screening for therapy-related late effects
    Saro H Armenian
    Department of Population Sciences, City of Hope National Medical Center, Duarte, California 91010 3000, USA
    Curr Opin Pediatr 25:16-22. 2013
    ....
  5. pmc Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation
    Saro H Armenian
    Department of Population Sciences, City of Hope, Duarte, CA 91010 3000, USA
    Blood 118:6023-9. 2011
    ....
  6. pmc Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study
    Can Lan Sun
    Department of Population Sciences, City of Hope National Medical Center, Duarte, CA, USA
    Biol Blood Marrow Transplant 19:1073-80. 2013
    ..Patients, families, and healthcare providers need to be made aware of the high burden, so they can plan for post-HCT care, even many years after HCT...
  7. pmc Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)
    Saro H Armenian
    Population Sciences, City of Hope, Duarte, CA 91010 3000, USA
    Blood 118:1413-20. 2011
    ....
  8. pmc Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation
    Saro H Armenian
    Department of Population Sciences, City of Hope, Duarte, California 91010 3000, USA
    Biol Blood Marrow Transplant 16:1138-44. 2010
    ..These data form the basis for developing predictive models for identifying high-risk individuals for targeted surveillance and aggressive management of comorbidities...
  9. pmc Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
    Saro H Armenian
    Department of Population Sciences, City of Hope National Medical Center, Duarte, CA 91010 3000, USA
    Cancer 116:4152-9. 2010
    ..Hispanics have a greater risk of early treatment failure after hematopoietic stem cell transplantation (HCT) compared with non-Hispanic whites. However, long-term morbidity among Hispanics has not been described...
  10. pmc Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines
    Wendy Landier
    City of Hope, Duarte, CA 91010 3000, USA
    J Clin Oncol 30:4401-8. 2012
    ..However, the yield from these recommendations is not known...
  11. pmc Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation
    Saro H Armenian
    Department of Population Sciences, Outcomes Research, City of Hope, Duarte, CA, USA
    Br J Haematol 163:205-13. 2013
    ..A combined (clinical and genetic) CHF predictive model performed better [area under the curve (AUC), 0·79] than the genetic (AUC = 0·67) or the clinical (AUC = 0·69) models alone...
  12. doi request reprint Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group
    Xuexia Wang
    Xuexia Wang, University of Wisconsin Milwaukee, Milwaukee, WI Wei Liu and Yutaka Yasui, University of Alberta Sunil Desai, Stollery Children s Hospital, Edmonton, AB, Canada Can Lan Sun, Saro H Armenian, Lindsey Hageman, Yan Ding, Wendy Landier, and Smita Bhatia, City of Hope, Duarte Lu Chen, University of Southern California, Los Angeles, CA Hakon Hakonarson and Jill P Ginsberg, Children s Hospital of Philadelphia, Philadelphia, PA Javier G Blanco, Alfo Quiñones, and Daniel Ferguson, The State University of New York at Buffalo, Buffalo Charles A Sklar, Memorial Sloan Kettering Cancer Center, New York City Irene Cherrick, Upstate Medical University, Syracuse, NY Naomi Winick, University of Texas Southwestern Medical Center, Dallas Zoann E Dreyer, Baylor College of Medicine, Houston, TX Frank Keller, Children s Healthcare of Atlanta and Emory University School of Medicine, Atlanta, London WC1E 7HT
    J Clin Oncol 32:647-53. 2014
    ..The high morbidity associated with cardiomyopathy necessitates an understanding of the underlying pathogenesis so that targeted interventions can be developed...
  13. ncbi request reprint Invasive diagnostic procedures for pulmonary infiltrates in pediatric hematopoietic stem cell transplant recipients
    Saro H Armenian
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, CA, USA
    Pediatr Transplant 11:736-42. 2007
    ..In conclusion, all three invasive diagnostic procedures were safe. Having a focal infiltrate was independently and significantly associated with having a positive diagnostic yield...
  14. pmc Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role?
    Saro H Armenian
    Department of Population Sciences, City of Hope National Medical Center, Duarte, CA, USA
    J Gen Intern Med 24:S395-400. 2009
    ..It is increasingly recognized that many of these complications result from complex interactions between therapeutic exposures and genetic susceptibility...
  15. pmc A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors
    Leo Mascarenhas
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 60:1103-7. 2013
    ..This trial evaluated the maximum tolerated dose (MTD) and dose limiting toxicities (DLT) of oxaliplatin combined with doxorubicin in pediatric patients with recurrent solid tumors...
  16. doi request reprint Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients
    Saro H Armenian
    Department of Population Sciences, City of Hope National Medical Center, Duarte, CA, USA
    J Pediatr Hematol Oncol 31:920-6. 2009
    ..We evaluated the utility of prospective monitoring for invasive aspergillosis (IA) using biomarkers such as serum galactomannan (GM) and/or blood polymerase chain reaction (PCR) in high-risk pediatric patients...
  17. doi request reprint Cardiovascular disease in survivors of hematopoietic cell transplantation
    Saro H Armenian
    Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, California
    Cancer 120:469-79. 2014
    ....
  18. ncbi request reprint Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience
    Catherine E Madigan
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Cancer 110:2061-6. 2007
    ..Extracranial malignant rhabdoid tumor (MRT) is a rare, aggressive, pediatric malignancy with a historically poor outcome. Recent efforts to intensify treatment for MRT have resulted in isolated reports of long-term survival...
  19. doi request reprint Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis
    Saro H Armenian
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, California, USA
    Pediatr Blood Cancer 51:479-84. 2008
    ..Little is known about the role of neoadjuvant therapy in the setting of orbital optic nerve enhancement on magnetic resonance imaging (MRI) at diagnosis...
  20. ncbi request reprint Evaluation of persistent pulmonary infiltrates in pediatric oncology patients
    Saro H Armenian
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 48:165-72. 2007
    ..To evaluate the role of bronchoalveolar lavage (BAL), computed-tomography-guided biopsy (CTB), and open lung biopsy (OLB) in the management of persistent pulmonary infiltrates in pediatric oncology patients...